Buscar
Scilex Holding Co
SCLXAñadir a la lista de seguimiento
6.665USD
+0.065+0.98%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
46.87MCap. mercado
PérdidaP/E TTM
Más Datos de Scilex Holding Co Compañía
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.
Información de Scilex Holding Co
Símbolo de cotizaciónSCLX
Nombre de la empresaScilex Holding Co
Fecha de salida a bolsaJan 11, 2021
Director ejecutivoJi (Henry H)
Número de empleados115
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 11
Dirección960 San Antonio Road
CiudadPALO ALTO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94303
Teléfono16505164310
Sitio Webhttps://www.scilexholding.com/
Símbolo de cotizaciónSCLX
Fecha de salida a bolsaJan 11, 2021
Director ejecutivoJi (Henry H)
Ejecutivos de Scilex Holding Co
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Henry H. Ji, Ph.D.
Dr. Henry H. Ji, Ph.D.
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
19.37K
-0.42%
Dr. Jay Chun, M.D., Ph.D.
Dr. Jay Chun, M.D., Ph.D.
Independent Director
Independent Director
3.21K
--
Dr. Yue Alexander Wu, Ph.D.
Dr. Yue Alexander Wu, Ph.D.
Independent Director
Independent Director
714.00
--
Mr. Dorman Followwill
Mr. Dorman Followwill
Independent Director
Independent Director
65.00
--
Mr. Stephen Ma
Mr. Stephen Ma
Chief Financial Officer, Chief Operating Officer, Senior Vice President, Corporate Secretary, Director
Chief Financial Officer, Chief Operating Officer, Senior Vice President, Corporate Secretary, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Henry H. Ji, Ph.D.
Dr. Henry H. Ji, Ph.D.
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
19.37K
-0.42%
Dr. Jay Chun, M.D., Ph.D.
Dr. Jay Chun, M.D., Ph.D.
Independent Director
Independent Director
3.21K
--
Dr. Yue Alexander Wu, Ph.D.
Dr. Yue Alexander Wu, Ph.D.
Independent Director
Independent Director
714.00
--
Mr. Dorman Followwill
Mr. Dorman Followwill
Independent Director
Independent Director
65.00
--
Mr. Stephen Ma
Mr. Stephen Ma
Chief Financial Officer, Chief Operating Officer, Senior Vice President, Corporate Secretary, Director
Chief Financial Officer, Chief Operating Officer, Senior Vice President, Corporate Secretary, Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Scilex Holding Co?
Los cinco principales accionistas de Scilex Holding Co son: Dr. Henry H. Ji, Ph.D.
¿Cuántas instituciones poseen acciones de Scilex Holding Co (SCLX)?
A fecha de 2026Q1, 258 instituciones poseen acciones de Scilex Holding Co, con un valor de mercado combinado de aproximadamente 1.44M, lo que representa el 16.97% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 401365.00.